HomeCompareRDSMY vs CHD

RDSMY vs CHD: Dividend Comparison 2026

RDSMY yields 29.34% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RDSMY wins by $259.68M in total portfolio value
10 years
RDSMY
RDSMY
● Live price
29.34%
Share price
$33.85
Annual div
$9.93
5Y div CAGR
42%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$259.71M
Annual income
$216,211,959.52
Full RDSMY calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — RDSMY vs CHD

📍 RDSMY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRDSMYCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RDSMY + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RDSMY pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RDSMY
Annual income on $10K today (after 15% tax)
$2,493.58/yr
After 10yr DRIP, annual income (after tax)
$183,780,165.59/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, RDSMY beats the other by $183,779,066.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RDSMY + CHD for your $10,000?

RDSMY: 50%CHD: 50%
100% CHD50/50100% RDSMY
Portfolio after 10yr
$129.87M
Annual income
$108,106,626.01/yr
Blended yield
83.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

RDSMY
Analyst Ratings
2
Buy
Consensus: Buy
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RDSMY buys
0
CHD buys
0
No recent congressional trades found for RDSMY or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRDSMYCHD
Forward yield29.34%1.27%
Annual dividend / share$9.93$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR42%23.1%
Portfolio after 10y$259.71M$26.4K
Annual income after 10y$216,211,959.52$1,292.51
Total dividends collected$256.08M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: RDSMY vs CHD ($10,000, DRIP)

YearRDSMY PortfolioRDSMY Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$14,866$4,165.74$10,856$156.32+$4.0KRDSMY
2$24,125$8,218.32$11,811$195.24+$12.3KRDSMY
3$43,513$17,699.56$12,883$244.38+$30.6KRDSMY
4$88,926$42,366.66$14,091$306.64+$74.8KRDSMY
5$210,055$114,904.40$15,463$385.88+$194.6KRDSMY
6$584,961$360,202.96$17,033$487.17+$567.9KRDSMY
7$1,957,119$1,331,210.45$18,843$617.36+$1.94MRDSMY
8$8,004,850$5,910,732.36$20,947$785.72+$7.98MRDSMY
9$40,648,692$32,083,502.25$23,419$1,004.91+$40.63MRDSMY
10$259,706,060$216,211,959.52$26,350$1,292.51+$259.68MRDSMY

RDSMY vs CHD: Complete Analysis 2026

RDSMYStock

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Full RDSMY Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this RDSMY vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RDSMY vs SCHDRDSMY vs JEPIRDSMY vs ORDSMY vs KORDSMY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.